GO:0032674 regulation of interleukin-5 production: Immune Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032674 (regulation of interleukin-5 production) is a biological process that modulates the frequency, rate, or extent of interleukin-5 (IL-5) production, including its biosynthesis and secretion.
• IL-5 is a key cytokine for eosinophil production, activation, and survival, and its regulation is central to type 2 immunity and allergic inflammation.
• Multiple cell types produce IL-5, including Th2 cells, group 2 innate lymphoid cells (ILC2s), and eosinophils themselves, with ILC2s acting as a non-redundant source for B1 cell development in mice.
• The Il4-Il13-Il5 locus undergoes chromatin remodeling that enables selective gene expression, a critical layer of regulation for IL-5 production.
• Dysregulated IL-5 production contributes to eosinophilic asthma, hypereosinophilic syndromes, and tissue fibrosis, making it a therapeutic target.
• Studying GO:0032674 requires integrated approaches such as CRISPR knockout, reporter knock-in, RNA-seq, and cytokine profiling to dissect regulatory networks.
Description
Interleukin-5 (IL-5) is a pleiotropic cytokine that governs eosinophil biology and type 2 immune responses. The Gene Ontology term GO:0032674, regulation of interleukin-5 production, encompasses any process that modulates the frequency, rate, or extent of IL-5 production, including its biosynthetic and secretory pathways. This term is essential for researchers investigating allergic inflammation, asthma, and eosinophil-mediated tissue damage, as IL-5 levels directly correlate with disease severity. Understanding the regulatory mechanisms of IL-5 production provides a foundation for therapeutic strategies targeting eosinophilic disorders. IL-5 production is tightly controlled at multiple levels, from chromatin remodeling at the Il4-Il13-Il5 locus to post-transcriptional and secretory regulation. Various cell types, including CD4+ Th2 cells, group 2 innate lymphoid cells (ILC2s), and eosinophils, contribute to IL-5 production, with distinct regulatory circuits. The GO term GO:0032674 captures the integration of these signals, offering a framework to study how external stimuli and intracellular networks converge to modulate IL-5 output. For biomedical researchers, GO:0032674 serves as a hub for understanding immune regulation and inflammation. Dysregulation of IL-5 production is implicated in eosinophilic asthma, hypereosinophilic syndromes, and fibrosis, where IL-5 drives eosinophil expansion and tissue remodeling. By dissecting the regulatory mechanisms, scientists can identify novel targets for intervention and develop biomarkers for patient stratification.
regulation of interleukin-5 production At A Glance
| GO ID | GO:0032674 |
|---|---|
| GO term | regulation of interleukin-5 production |
| Ontology | biological_process |
| Synonym | regulation of IL-5 production; regulation of interleukin-5 biosynthetic process; regulation of interleukin-5 secretion |
| Major function | Modulates the frequency, rate, or extent of interleukin-5 production, impacting eosinophil development and type 2 immunity |
| Key cell types | Th2 cells, ILC2s, eosinophils, mast cells, and B1 cells |
| Key regulatory locus | Il4-Il13-Il5 cytokine gene cluster on human chromosome 5q31 |
| Associated diseases | Eosinophilic asthma, hypereosinophilic syndrome, fibrosis, allergic rhinitis |
| Research methods | CRISPR knockout, reporter assays, RNA-seq, ChIP-seq, cytokine profiling |
What Is GO:0032674?
GO:0032674, regulation of interleukin-5 production, is defined as any process that modulates the frequency, rate, or extent of interleukin-5 production. This includes the regulation of IL-5 biosynthesis, secretion, and overall levels. It is a biological process term that encompasses both positive and negative regulation of IL-5 production, integrating signals from transcription factors, chromatin modifiers, and cytokine feedback loops.
Why Is regulation of interleukin-5 production Important in Cell Biology?
Regulation of interleukin-5 production is critically important because IL-5 is the principal cytokine driving eosinophil differentiation, activation, and survival, and its dysregulation underlies a spectrum of allergic and inflammatory diseases. Understanding GO:0032674 helps researchers identify molecular switches that control IL-5 levels, offering opportunities to modulate eosinophilic inflammation in asthma, hypereosinophilic syndromes, and tissue fibrosis. Moreover, IL-5 produced by ILC2s is essential for B1 cell development, highlighting its broader role in immune homeostasis.
• IL-5 is a key driver of eosinophil production and function, making its regulation central to eosinophilic disorders.
• Dysregulated IL-5 production is associated with severe eosinophilic asthma and hypereosinophilic syndromes.
• IL-5 from ILC2s is required for murine B1 cell development and function, linking it to innate-like B cell immunity.
• The Il4-Il13-Il5 locus undergoes dynamic chromatin remodeling that controls selective cytokine expression.
• IL-5 regulates beta2-integrin adhesion of human eosinophils via phosphoinositide 3-kinase, affecting tissue recruitment.
• Targeting IL-5 or its receptor is a validated therapeutic strategy in eosinophilic asthma.
• Understanding IL-5 regulation can inform vaccine adjuvant design and allergy therapies.
• IL-5 production is modulated by transcription factors such as GATA3, NFAT, and AP-1, offering druggable nodes.
• Single-cell technologies reveal heterogeneity in IL-5-producing cell populations, aiding precision medicine.
• GO:0032674 provides a standardized framework for annotating gene functions in immune regulation.
What Happens During regulation of interleukin-5 production?
Transcriptional activation of the IL5 gene
In simple terms: The cell turns on the IL5 gene to start making IL-5 protein.
Regulation of IL-5 production begins with transcriptional activation of the IL5 gene in response to immune stimuli. Transcription factors such as GATA3, NFAT, and AP-1 bind to the IL5 promoter and enhancer regions, recruiting coactivators and RNA polymerase II. This process is tightly controlled by signaling pathways downstream of T cell receptor and cytokine receptors, including the calcineurin-NFAT and MAPK pathways. Chromatin accessibility at the Il4-Il13-Il5 locus is a prerequisite for transcription, and remodeling of this locus enables selective gene expression.
Epigenetic remodeling of the Il4-Il13-Il5 locus
In simple terms: The DNA packaging around the IL-5 gene loosens so the gene can be read.
The Il4-Il13-Il5 cytokine gene cluster undergoes dynamic changes in chromatin structure that regulate IL-5 production. Histone modifications, DNA methylation, and higher-order chromatin looping control the accessibility of the IL5 promoter to transcription factors. Studies using chromosome conformation capture have shown that the locus adopts cell-type-specific conformations that facilitate or repress IL-5 expression. This epigenetic layer ensures that IL-5 is produced only in appropriate contexts, such as during type 2 immune responses.
Post-transcriptional regulation of IL-5 mRNA
In simple terms: After the gene is turned on, the RNA message can be stabilized or degraded to control how much protein is made.
IL-5 mRNA stability and translation are regulated by RNA-binding proteins and microRNAs. AU-rich elements in the 3' untranslated region of IL5 mRNA mediate rapid degradation, and their modification can enhance or reduce IL-5 production. Signaling pathways such as p38 MAPK can stabilize IL-5 mRNA, leading to increased cytokine secretion. This post-transcriptional control allows cells to fine-tune IL-5 output in response to sustained or transient stimuli.
Secretion and feedback regulation
In simple terms: The cell releases IL-5 and can sense it to adjust production.
Once synthesized, IL-5 is secreted through the classical endoplasmic reticulum-Golgi pathway. Secretion can be modulated by factors that affect vesicular trafficking and exocytosis. IL-5 can also feed back on producer cells or nearby cells to modulate its own production, although the exact feedback loops are context-dependent. Additionally, IL-5 acts on eosinophils to promote their survival and activation, which in turn can influence the immune microenvironment and further IL-5 production.
Cellular sources and heterogeneity
In simple terms: Different cell types can make IL-5, and they do it in different ways.
IL-5 is produced by multiple cell types, including CD4+ Th2 cells, group 2 innate lymphoid cells (ILC2s), eosinophils, mast cells, and B1 cells. ILC2s are a non-redundant source of IL-5 required for murine B1 cell development and function. The regulation of IL-5 production differs among these cell types, with distinct transcription factor dependencies and signaling requirements. Single-cell RNA sequencing has revealed heterogeneity even within a given cell type, highlighting the complexity of GO:0032674.
Key Genes Involved in GO:0032674 regulation of interleukin-5 production
The following genes and proteins are key players in the regulation of interleukin-5 production, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL5 | Encodes interleukin-5 cytokine | Central to eosinophil biology; target for knockout and reporter assays |
| GATA3 | Transcription factor essential for Th2 cytokine expression | Regulates IL5 promoter activity; knockout reduces IL-5 production |
| NFATC1 | Calcineurin-responsive transcription factor | Binds IL5 enhancer; mediates TCR-induced IL-5 production |
| IL4 | Cytokine co-regulated with IL5 in Th2 locus | Shares regulatory elements; knockout affects IL-5 levels |
| IL13 | Cytokine co-regulated with IL5 | Locus remodeling influences IL-5 expression |
| RAD50 | DNA repair protein involved in locus conformation | May affect chromatin looping at Il4-Il13-Il5 locus |
| STAT6 | Signal transducer downstream of IL-4/IL-13 | Modulates IL-5 production in allergic inflammation |
| IRF4 | Transcription factor in Th2 and ILC2 cells | Required for optimal IL-5 production |
| BCL11B | Transcription factor in T cells | Regulates Th2 cytokine expression including IL-5 |
| MAF | Transcription factor in Th2 cells | Controls IL-5 production and eosinophil recruitment |
| PIK3CD | Phosphoinositide 3-kinase catalytic subunit | Regulates IL-5-induced eosinophil adhesion |
| IL5RA | IL-5 receptor alpha chain | Mediates IL-5 signaling; target for inhibition |
| CSF2 | GM-CSF, co-regulated with IL-5 in some contexts | Shares signaling pathways; affects eosinophil production |
| IL33 | Alarmin that activates ILC2s | Induces IL-5 production in ILC2s |
| TSLP | Thymic stromal lymphopoietin | Promotes IL-5 production in allergic inflammation |
| NOTCH1 | Notch signaling receptor | Influences ILC2 IL-5 production |
| GATA2 | Transcription factor in ILC2s and mast cells | Regulates IL-5 expression in innate cells |
How Is regulation of interleukin-5 production Regulated?
Regulation of interleukin-5 production is controlled by a network of signaling pathways and transcription factors. The calcineurin-NFAT pathway is activated by T cell receptor engagement and promotes IL5 transcription. The p38 MAPK pathway stabilizes IL-5 mRNA and enhances secretion. Cytokines such as IL-33 and TSLP activate ILC2s to produce IL-5, while IL-4 and IL-13 amplify Th2 responses. Negative regulation involves feedback inhibition by IL-5 itself and by regulatory T cells. Epigenetic modifiers, including histone acetyltransferases and DNA methyltransferases, also modulate IL5 locus accessibility.
regulation of interleukin-5 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL5 | Eosinophilic asthma | IL5 knockout mouse; eosinophil counts and airway inflammation |
| IL5RA | Hypereosinophilic syndrome | IL5RA knockout or point mutation to block signaling |
| GATA3 | Allergic inflammation | Conditional GATA3 knockout in T cells; IL-5 production assay |
| IL33 | Asthma exacerbation | IL33 knockout or overexpression in lung epithelium |
| STAT6 | Type 2 immunity | STAT6 knockout; IL-5 levels after allergen challenge |
Eosinophilic asthma
Eosinophilic asthma is characterized by elevated IL-5 levels, which drive eosinophil proliferation, activation, and survival in the airways. Regulation of IL-5 production is therefore a central mechanism in disease pathogenesis, and therapies targeting IL-5 or its receptor have shown efficacy in reducing exacerbations. Understanding GO:0032674 helps identify upstream regulators that could be targeted to dampen eosinophilic inflammation.
Hypereosinophilic syndromes
Hypereosinophilic syndromes are a group of disorders marked by persistent eosinophilia and organ damage. Dysregulated IL-5 production, often from clonal or reactive T cells, contributes to eosinophil expansion. The regulation of IL-5 production is a key area of research for developing novel therapeutics, as current treatments often rely on corticosteroids or IL-5 blockade.
Tissue fibrosis
Type 2 immunity, including IL-5-driven eosinophilia, is implicated in tissue repair and fibrosis. IL-5 can promote eosinophil accumulation in tissues, where eosinophils release factors that stimulate fibroblasts and extracellular matrix deposition. Regulation of IL-5 production thus influences the balance between repair and pathological fibrosis, making it a potential target for antifibrotic strategies.
From regulation of interleukin-5 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IL-5 production? | CRISPR knockout of gene X in Th2 or ILC2 cells, followed by IL-5 ELISA |
| Does a point mutation in IL5 promoter affect transcription? | CRISPR point mutation knock-in of the mutation, reporter assay |
| Where is IL-5 produced in vivo? | IL5-tdTomato or IL5-GFP knock-in reporter mouse |
| Can overexpression of gene Y enhance IL-5 production? | Lentiviral overexpression of gene Y in primary T cells |
| What is the chromatin state at the IL5 locus? | CRISPR knockout of chromatin modifiers, ATAC-seq and ChIP-seq |
| Does IL-5 from ILC2s support B1 cells? | IL5 conditional knockout in ILC2s; B1 cell adoptive transfer |
How to Study the regulation of interleukin-5 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | IL-5 protein concentration | Quantify IL-5 in supernatants after CRISPR knockout |
| RNA-seq | IL5 mRNA and transcriptome | Identify co-regulated genes and pathways |
| ATAC-seq | Chromatin accessibility | Assess Il5 locus openness after epigenetic perturbation |
| ChIP-seq | Transcription factor binding | Map GATA3, NFAT binding at IL5 promoter |
| Flow cytometry | Intracellular IL-5 protein | Identify IL-5+ cells in mixed populations |
| Reporter assay | IL-5 promoter activity | Test point mutations in IL5 regulatory elements |
| Luminex | Multiplex cytokine levels | Profile IL-5 alongside other Th2 cytokines |
| CRISPR screen | Genes regulating IL-5 production | Unbiased discovery of regulators |
Cytokine profiling by ELISA and Luminex
Quantification of IL-5 protein levels in cell culture supernatants or serum is typically performed using enzyme-linked immunosorbent assay (ELISA) or multiplex bead-based assays. These methods are essential to measure the output of GO:0032674 and to validate genetic perturbations.
RNA sequencing and single-cell transcriptomics
RNA-seq can measure IL5 mRNA levels and identify co-regulated genes, while single-cell RNA-seq reveals heterogeneity in IL-5-producing cell populations. These approaches help dissect the transcriptional networks controlling IL-5 production.
Chromatin accessibility and conformation assays
ATAC-seq, ChIP-seq, and chromosome conformation capture (e.g., Hi-C) are used to study the epigenetic and architectural regulation of the Il4-Il13-Il5 locus. These methods provide insights into how chromatin remodeling influences IL-5 production.
Flow cytometry and reporter assays
Intracellular cytokine staining and IL-5 reporter cell lines enable the identification and isolation of IL-5-producing cells. Reporter mice expressing fluorescent proteins under the Il5 promoter allow tracking of IL-5 production in vivo.
How CRISPR Can Be Used to Study GO:0032674 regulation of interleukin-5 production
Knockout
CRISPR knockout of candidate genes in Th2 or ILC2 cells can determine whether they are required for IL-5 production. For example, knocking out GATA3 or NFATC1 reduces IL-5 levels, confirming their roles in GO:0032674. Knockout models also help identify non-redundant regulators, such as ILC2-derived IL-5 for B1 cell development.
Point Mutation
Point mutations in the IL5 promoter or enhancer can be introduced using CRISPR base editing or homology-directed repair to study the impact of specific variants on IL-5 production. This approach is useful for dissecting regulatory elements identified by GWAS or epigenomic profiling.
Knock-in
Knock-in of reporter genes (e.g., GFP, tdTomato) at the IL5 locus allows real-time tracking of IL-5-producing cells and isolation of live populations for downstream analysis. Tagged knock-in of IL-5 with epitope tags facilitates protein interaction studies.
Overexpression
Overexpression of candidate regulators (e.g., GATA3, IL-33) via lentiviral transduction can enhance IL-5 production and help establish sufficiency. This is particularly useful for studying signaling pathways that amplify type 2 responses.
How EDITGENE Supports regulation of interleukin-5 production Research
Researchers studying regulation of interleukin-5 production-related genes often need to determine whether a candidate gene is causally involved in IL-5 regulation or is merely correlated with changes in expression. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic perturbations and functional validation in relevant immune cell models.
Contact EDITGENE today to design your custom CRISPR model for regulation of interleukin-5 production research.
Frequently Asked Questions About regulation of interleukin-5 production
What is GO:0032674?
GO:0032674 is the Gene Ontology term for regulation of interleukin-5 production, defined as any process that modulates the frequency, rate, or extent of interleukin-5 production.
What genes are involved in regulation of interleukin-5 production?
Key genes include IL5, GATA3, NFATC1, IL4, IL13, STAT6, IRF4, and IL5RA, among others.
Which cells produce interleukin-5?
IL-5 is produced by Th2 cells, group 2 innate lymphoid cells (ILC2s), eosinophils, mast cells, and B1 cells.
How is interleukin-5 production regulated?
IL-5 production is regulated at transcriptional, epigenetic, post-transcriptional, and secretory levels by factors such as GATA3, NFAT, chromatin remodeling, and mRNA stability.
What diseases are associated with dysregulated IL-5 production?
Eosinophilic asthma, hypereosinophilic syndromes, and tissue fibrosis are associated with dysregulated IL-5 production.
What methods are used to study regulation of interleukin-5 production?
Common methods include ELISA, RNA-seq, ATAC-seq, ChIP-seq, flow cytometry, and CRISPR screens.
Can CRISPR be used to study IL-5 regulation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect IL-5 regulatory mechanisms.
What is the role of ILC2s in IL-5 production?
ILC2s are a non-redundant source of IL-5 required for murine B1 cell development and function.
How does the Il4-Il13-Il5 locus regulate IL-5?
The locus undergoes chromatin remodeling and conformational changes that enable selective expression of IL-5.
What is the clinical significance of IL-5 regulation?
Targeting IL-5 or its receptor is a validated therapeutic strategy for eosinophilic asthma, highlighting the clinical importance of understanding its regulation.
Conclusion
GO:0032674, regulation of interleukin-5 production, is a critical biological process that governs eosinophil biology and type 2 immunity. Its dysregulation contributes to allergic and inflammatory diseases, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and multi-omics approaches are accelerating the discovery of novel regulators and their mechanisms. EDITGENE offers comprehensive services to support researchers in dissecting this pathway and translating findings into clinical applications.
References
- 1. Gieseck RL 3rd et al.. 2018. Type 2 immunity in tissue repair and fibrosis.. Nat Rev Immunol 18(1):62-76 PMID: 28853443
- 2. Roboz GJ et al.. 1999. Interleukin-5 and the regulation of eosinophil production.. Curr Opin Hematol 6(3):164-8 PMID: 10226737
- 3. Troch KF et al.. 2024. Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells.. Nat Commun 15(1):10566 PMID: 39632879
- 4. Takatsu K. 2004. [Role of interleukin-5 in immune regulation and inflammation].. Nihon Rinsho 62(10):1941-51 PMID: 15500144
- 5. Lopez AF et al.. 1992. Regulation of human eosinophil production and function by interleukin-5.. Immunol Ser 57:549-71 PMID: 1504148
- 6. Mordvinov VA et al.. 2001. Regulation of IL-5 expression.. Arch Immunol Ther Exp (Warsz) 49(5):345-51 PMID: 11798132
- 7. Nagashima H et al.. 2024. Remodeling of Il4-Il13-Il5 locus underlies selective gene expression.. Nat Immunol 25(12):2220-2233 PMID: 39567762
- 8. Sano M et al.. 2005. Regulation of interleukin-5-induced beta2-integrin adhesion of human eosinophils by phosphoinositide 3-kinase.. Am J Respir Cell Mol Biol 33(1):65-70 PMID: 15802551
